AMC Robotics achieves adjusted profitability in 2025 as NovaArm™ commercialization nears

AMC Robotics (NASDAQ:AMCI) today reported its financial results for the full year ended December 31, 2025, marking a transition point as the company nears the commercial rollout of its core technology suite.

The results demonstrate a strengthening operational profile, characterized by high margins and the attainment of adjusted profitability.

For the fiscal year, AMC Robotics recorded revenue of $6 million with a robust gross margin of 48%.

While the company reported a GAAP net loss of $24.8 million, the figure was almost entirely driven by a $25.5 million non-cash charge related to the fair value change of PIPE warrants.

On an operational basis, the company achieved adjusted net income of $0.7 million and adjusted EBITDA of $0.8 million, signaling that its underlying business model is reaching a self-sustaining level.

The company also significantly bolstered its financial foundation during the year, raising $8 million in PIPE financing.

This capital infusion helped AMC Robotics end the year with $7.0 million in cash and move to a positive equity position of $10.4 million.

The primary focus for the first half of 2026 is the commercialization of NovaArm™, the company’s flagship robotic solution.

Management confirmed that the commercial launch is targeted for the second quarter of 2026.

Simultaneously, the company reported steady progress in the development of Kyro™, its next-generation automation platform, which is expected to expand the company’s addressable market in late 2026.